TORL Biotherapeutics LLC
Culver City, CA
LAST FUNDING
$158.3M
Series C
Funding history
DateRoundAmountInvestorsSource
—Series C$158.3M——
About TORL Biotherapeutics LLC
How much funding has TORL Biotherapeutics LLC raised?
TORL Biotherapeutics LLC has raised $158.3M in total funding. The most recent round was Series C.
Where is TORL Biotherapeutics LLC headquartered?
TORL Biotherapeutics LLC is headquartered in Culver City, CA.
What makes TORL Biotherapeutics LLC notable?
Founded in 2019 with co-founder Dave Licata, and has raised over $450 million total, with investors including Goldman Sachs Asset Management and Blue Owl Capital.
Leadership
Mark Alles
Executive Officer, Director
David Licata
Executive Officer, Director
Mark Attanasio
Director
Neil O'Brien
Director
Lynn Seely
Director
Amit Sinha
Director
Dennis Slamon
Director
Avenzo Therapeutics, Inc.
San Diego, CA
ImmunityBio, Inc.
San Diego, CA
Mirador Therapeutics, Inc.
San Diego, CA
Avidity Biosciences, Inc.
San Diego, CA
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 27, 2026.
MLA
"TORL Biotherapeutics LLC: Funding & Investors." SoCal.Startups, August 27, 2026, https://socalstartups.io/companies/city/culver-city/healthcare/torl-biotherapeutics-llc. Accessed August 27, 2026.
APA
SoCal.Startups. (2026). TORL Biotherapeutics LLC: Funding & Investors. Retrieved August 27, 2026, from https://socalstartups.io/companies/city/culver-city/healthcare/torl-biotherapeutics-llc
WIKIPEDIA (CITE WEB)
{{cite web |title=TORL Biotherapeutics LLC: Funding & Investors |url=https://socalstartups.io/companies/city/culver-city/healthcare/torl-biotherapeutics-llc |website=SoCal.Startups |access-date=August 27, 2026}}